Alain Daugan
GlaxoSmithKline (France)(FR)GlaxoSmithKline (Netherlands)(NL)Directorate-General Joint Research Centre(BE)
Publications by Year
Research Areas
Plant-derived Lignans Synthesis and Bioactivity, Phytochemistry and Biological Activities, Biochemical Acid Research Studies, Biological Activity of Diterpenoids and Biflavonoids, Research on Leishmaniasis Studies
Most-Cited Works
- → Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains(2013)302 cited
- → The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1‘,2‘:1,6]pyrido[3,4-b]indole-1,4-dione Analogues(2003)279 cited
- → The Discovery of Tadalafil: A Novel and Highly Selective PDE5 Inhibitor. 1: 5,6,11,11a-Tetrahydro-1H-imidazo[1‘,5‘:1,6]pyrido[3,4-b]indole-1,3(2H)-dione Analogues(2003)192 cited
- → Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase(2019)68 cited
- → Pharmacological inhibition of Stearoyl-CoA Desaturase 1 improves insulin sensitivity in insulin-resistant rat models(2009)51 cited
- → Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis(2018)